US Doctor Groups Debate Best Use Of New Weight-loss Drugs

As powerful new obesity drugs enter the U.S. market, medical associations are keen to advise their members on how to best use them for patients. That is where the debate begins.

Related Keywords

San Francisco ,California ,United States ,Canada ,American ,Americans ,Caroline Apovian ,Anthony Comuzzie ,Prakash Deedwania ,Novo Nordisk Wegovy ,Eli Lilly ,Novo Nordisk ,Endocrine Society ,Wake Forest University ,American Heart Association ,American College Of Cardiology ,Harvard Medical School Center ,University Of California ,American Medical Association ,Reuters ,Obesity Society ,American Association Of Clinical Endocrinology ,U Endocrine Society ,American College ,American Association ,Clinical Endocrinology ,Harvard Medical School ,Weight Management ,Jamy Ard ,National , ,